0001033409-11-000004.txt : 20111206
0001033409-11-000004.hdr.sgml : 20111206
20111206091024
ACCESSION NUMBER: 0001033409-11-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111205
FILED AS OF DATE: 20111206
DATE AS OF CHANGE: 20111206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ESHELMAN FREDRIC N
CENTRAL INDEX KEY: 0001033409
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-27570
FILM NUMBER: 111244557
MAIL ADDRESS:
STREET 1: PPD INC
STREET 2: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC
CENTRAL INDEX KEY: 0001003124
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 561640186
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
BUSINESS PHONE: 9102510081
MAIL ADDRESS:
STREET 1: 929 NORTH FRONT STREET
CITY: WILMINGTON
STATE: NC
ZIP: 28401
4
1
edgar.xml
PRIMARY DOCUMENT
X0304
4
2011-12-05
1
0001003124
PHARMACEUTICAL PRODUCT DEVELOPMENT INC
PPDI
0001033409
ESHELMAN FREDRIC N
929 NORTH FRONT STREET
WILMINGTON
NC
28401
1
1
0
0
Executive Chairman
Common Stock
2011-04-14
5
J
0
15000
0
D
394500
I
GRAT
Common Stock
2011-04-14
5
J
0
15000
0
A
6984741
D
Common Stock
2011-12-05
4
D
0
6984741
33.25
D
0
D
Common Stock
2011-12-05
4
D
0
394500
33.25
D
0
I
GRAT
Common Stock
2011-12-05
4
D
0
11258
33.25
D
0
I
LLC
Common Stock
2011-12-05
4
D
0
1685
33.25
D
0
I
Spouse
Stock Options (to buy)
27.27
2011-12-05
4
D
0
90000
0
D
Common Stock
90000
0
D
Stock Options (to buy)
20.45
2011-12-05
4
D
0
103506
0
D
Common Stock
103506
0
D
Stock Options (to buy)
25.74
2011-12-05
4
D
0
103506
0
D
Common Stock
103506
0
D
Stock Options (to buy)
19.94
2011-12-05
4
D
0
51753
0
D
Common Stock
51753
0
D
Stock Options (to buy)
43.26
2011-12-05
4
D
0
103506
0
D
Common Stock
103506
0
D
Stock Options (to buy)
32.47
2011-12-05
4
D
0
51753
0
D
Common Stock
51753
0
D
Stock Options (to buy)
33.44
2011-12-05
4
D
0
207012
0
D
Common Stock
207012
0
D
Stock Options (to buy)
20.47
2011-12-05
4
D
0
258764
0
D
Common Stock
258764
0
D
Stock Options (to buy)
14.78
2011-12-05
4
D
0
124207
0
D
Common Stock
124207
0
D
Stock Options (to buy)
14.44
2011-12-05
4
D
0
41403
0
D
Common Stock
41403
0
D
Restricted Stock Units
2011-12-05
4
D
0
30000
0
D
Common Stock
30000
0
D
Pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Pharmaceutical Prodcut Development, Inc., Jaguar Holdings, LLC and Jaguar Merger Sub, Inc. dated as of October 2, 2011, on the effective date of the merger contemplated by the Agreement (the "Merger"), each of these shares of common stock was automatically converted into the right to receive $33.25.
The stock options were cancelled pursuant to the Agreement on the effective date of the Merger in exchange for a cash payment equal to the difference (if any ) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14 but vesting was accelerated due to the Merger.
These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/25/11, 2/25/12 and 2/25/13 but vesting was accelerated due to the Merger.
These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes. The options were scheduled to vest in three equal increments on 2/18/10, 2/18/11 and 2/18/12 but vesting was accelerated due to the Merger.
These stock options were cancelled pursuant to the Merger in exchange for a cash payment equal to the difference (if any) between the exercise price of the stock options and $33.25 multiplied by the number of shares subject to such stock options less any applicable withholding taxes.
Each restricted stock unit (RSU) represents a contingent right to receive one share of PPDI common stock. The RSUs were scheduled to vest in three equal increments on 2/23/12, 2/23/13 and 2/23/14 but became fully vested pursuant to the terms of the Agreement. The RSUs were disposed of pursuant to the terms of the Agreement in exchange for a cash payment of $33.25 per share upon the effective date of the Merger.
Lisa C. Noecker attorney-in-fact for Fred N. Eshelman
2011-12-06